| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 10/04/2001 | WO2001072336A1 Compounds for targeting |
| 10/04/2001 | WO2001072329A1 Compositions and methods for enhancing immunogenicity of antigens |
| 10/04/2001 | WO2001072325A1 Methods of blocking tissue destruction by autoreactive t cells |
| 10/04/2001 | WO2001072295A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 10/04/2001 | WO2001016319A3 Compositions and methods for the treatment of immune related diseases |
| 10/04/2001 | WO2000071564A8 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer |
| 10/04/2001 | EP1137941A1 Protein scaffolds for antibody mimics and other binding proteins |
| 10/04/2001 | EP1137812A1 Dna-protein fusions and uses thereof |
| 10/04/2001 | EP1137787A1 Enhanced protein production in higher plants by n-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide |
| 10/04/2001 | EP1137779A2 Identification of senv genotypes |
| 10/04/2001 | EP1137773A2 Growth factor homolog zvegf3 |
| 10/04/2001 | EP1137771A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor |
| 10/04/2001 | EP1137763A1 Glucoamylases with n-terminal extensions |
| 10/04/2001 | EP1137664A2 Protein transduction system and methods of use thereof |
| 10/04/2001 | EP1137442A1 Biologically active conjugates having a detectable reporter moiety and method of identification of said derivative |
| 10/04/2001 | CA2404756A1 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 10/04/2001 | CA2404496A1 Calcium binding regulatory subunit |
| 10/04/2001 | CA2404495A1 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 10/04/2001 | CA2404489A1 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same |
| 10/04/2001 | CA2404233A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 10/04/2001 | CA2404164A1 Compositions and methods for enhancing immunogenicity of antigens |
| 10/04/2001 | CA2404160A1 Identification of new human gaba transporter |
| 10/04/2001 | CA2403909A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 10/04/2001 | CA2403857A1 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 10/04/2001 | CA2403800A1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 10/04/2001 | CA2403750A1 Human survivin interacting protein 1 (sip-1) |
| 10/04/2001 | CA2403515A1 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 10/04/2001 | CA2402453A1 Compounds for targeting |
| 10/04/2001 | CA2402098A1 Method for genetically modifying a plant |
| 10/03/2001 | CN1316002A Polyketides, their preparation, and materials for use therein |
| 10/03/2001 | CN1316001A Polyketides and their synthesis |
| 10/03/2001 | CN1315956A Polyketides and their synthesis |
| 10/03/2001 | CN1315869A Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 10/02/2001 | US6296853 For therapy of animal having a papilloma viral infection |
| 10/02/2001 | US6296843 Mutagenized IL 13-based chimeric molecules |
| 09/27/2001 | WO2001071358A1 Method of screening for inhibitors of osteopontin |
| 09/27/2001 | WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | WO2001071004A2 Proteases |
| 09/27/2001 | WO2001070985A2 Bi-functional cancer treatment agents |
| 09/27/2001 | WO2001070984A2 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 09/27/2001 | WO2001070977A2 Fibroblast growth factor receptor-like molecules and uses thereof |
| 09/27/2001 | WO2001070952A1 Human gata-5 transcription factor |
| 09/27/2001 | WO2001070945A1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments |
| 09/27/2001 | WO2001070798A2 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | WO2001070771A2 Acute neuronal induced calcium binding protein type 1 ligand |
| 09/27/2001 | WO2001016170A3 Card proteins involved in cell death regulation |
| 09/27/2001 | WO2001014539A3 Methods and compositions for the construction and use of fusion libraries |
| 09/27/2001 | US20010025097 Somatostatins and methods |
| 09/27/2001 | US20010025026 Chimeric proteins for use in transport of a selected substance into cells |
| 09/27/2001 | CA2406993A1 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | CA2404088A1 Bi-functional cancer treatment agents |
| 09/27/2001 | CA2403572A1 Fibroblast growth factor receptor-like molecules and uses thereof |
| 09/27/2001 | CA2403436A1 Acute neuronal induced calcium binding protein type 1 ligand |
| 09/27/2001 | CA2403434A1 Human gata-5 transcription factor |
| 09/27/2001 | CA2402763A1 Proteases |
| 09/27/2001 | CA2402596A1 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 09/27/2001 | CA2401887A1 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/26/2001 | EP1136556A1 Multivalent antigen-binding proteins |
| 09/26/2001 | EP1136500A2 Seroreactive regions from the HPV proteins E1 and E2 |
| 09/26/2001 | EP1135509A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/26/2001 | EP1135501A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/26/2001 | EP1135495A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 09/26/2001 | EP1135491A2 Methods and compositions for inhibiting neoplastic cell growth |
| 09/26/2001 | EP1135485A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/26/2001 | EP1135468A1 Virus vectors and methods of making and administering the same |
| 09/26/2001 | EP1135412A2 Tumor necrosis factor receptor homologue-1 (trh1) |
| 09/26/2001 | EP1135408A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| 09/26/2001 | EP0771325B1 Process for modifying the stability of antibodies |
| 09/25/2001 | US6294654 Modified immunoglobulin molecule incorporating an antigen in a non-CDR loop region |
| 09/25/2001 | US6294353 Targeted hetero-association of recombinant proteins to multi-functional complexes |
| 09/25/2001 | US6294322 Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1 |
| 09/20/2001 | WO2001068888A2 Production of chimeric capsid vectors |
| 09/20/2001 | WO2001068852A2 Apolipoprotein-a-i regulation of t-cell signalling |
| 09/20/2001 | WO2001068848A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | WO2001068824A2 Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 09/20/2001 | WO2001068805A2 Human olfactory receptors and genes encoding same |
| 09/20/2001 | WO2001068708A2 Human and humanized fap-alpha-specific antibodies |
| 09/20/2001 | WO2001068706A1 Melanin concentrating hormone receptor chimeric and fusion proteins |
| 09/20/2001 | WO2001068705A2 Il-17 receptor like molecules and uses thereof |
| 09/20/2001 | WO2001068695A2 Factor-h related protein 5 (fhr-5) and antibodies thereto |
| 09/20/2001 | WO2001068682A1 Self antigen vaccines for treating b cell lymphomas and other cancers |
| 09/20/2001 | WO2001018051A3 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 09/20/2001 | WO2001014424A3 Human ctla-4 antibodies and their uses |
| 09/20/2001 | WO2000046246A8 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease |
| 09/20/2001 | CA2539214A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2534391A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2534186A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2534030A1 Screted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2534018A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2533991A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2533903A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2533831A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2531917A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2402877A1 Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same |
| 09/20/2001 | CA2402772A1 Apolipoprotein-a-i regulation of t-cell signalling |
| 09/20/2001 | CA2402147A1 Melanin concentrating hormone receptor chimeric and fusion proteins |
| 09/20/2001 | CA2402086A1 Self antigen vaccines for treating b cell lymphomas and other cancers |
| 09/20/2001 | CA2401448A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/20/2001 | CA2401406A1 Human olfactory receptors and genes encoding same |
| 09/20/2001 | CA2401273A1 Il-17 receptor like molecules and uses thereof |